Page 258 - Pagetit
P. 258

7. ETHICAL ISSUES IN NEUROSCIENCE RESEARCH ON SUBSTANCE DEPENDENCE TREATMENT AND PREVENTION



                     Cornblatt BA, Lencz T, Kane JM (2001) Treatment of the schizophrenia prodrome:
                     is it presently ethical? Schizophrenia Research, 51:31–38.
                     Davidoff F et al. (2001) Sponsorship, authorship, and accountability. New England
                     Journal of Medicine, 345:825–827.
                     de Angelis CD, Fontanarosa PB, Flanagin A (2001) Reporting financial conflicts
                     of interest and relationships between investigators and research sponsors. Journal
                     of the American Medical Association, 286:89–91.
                     de Grazia D (2001) Ethical issues in early-intervention clinical trials involving
                     minors at risk for schizophrenia. Schizophrenia Research, 51:77–86.
                     Dolan K (1996) HIV risk behaviour of IDUs before, during and after imprisonment
                     in New South Wales. Addiction Research, 4:151–160.
                     Fergusson DM, Horwood LJ (2000) Cannabis use and dependence in a New
                     Zealand birth cohort. New Zealand Medical Journal, 113:156–158.
                     Fox BS (1997) Development of a therapeutic vaccine for the treatment of cocaine
                     addiction. Drug and Alcohol Dependence, 48:153–158.
                     Fox BS et al. (1996) Efficacy of a therapeutic cocaine vaccine in rodent models.
                     Nature Medicine, 2:1129–1132.
                     Fox RG (1992) The compulsion of voluntary treatment in sentencing. Criminal
                     Law Journal, 16:37–54.
                     Fu CH, McGuire PK (1999) Functional neuroimaging in psychiatry. Philosophical
                     Transactions of the Royal Society of London (Series B: Biological Sciences),
                     354:1359–1370.
                     General Accounting Office (1995) Drug courts: information on a new approach to
                     address drug-related crime. Washington, DC, United States General Accounting
                     Office.
                     Gerstein DR, Harwood HJ (1990) Treating drug problems. Vol. 1. A study of
                     effectiveness and financing of public and private drug treatment systems.
                     Washington, DC, National Academy Press.
                     Gilman S (1998) Imaging the brain: first of two parts. New England Journal of
                     Medicine, 338:812–820.
                     Gorelick D et al. (1999) Clinical research in substance abuse: human subjects
                     issues. In: Pincus HA et al., eds. Ethics in psychiatric research: a resource manual
                     for human subjects protection. Washington, DC, American Psychiatric
                     Association:177–218.
                     Gostin LO (1991) Compulsory treatment for drug-dependent persons:
                     justifications for a public health approach to drug dependency. Milbank Quarterly,
                     69:561–593.
                     Gostin LO, Mann JM (1999) Toward the development of a human rights impact
                     assessment for the formulation and evaluation of public health policies. In: Mann
                     JM et al., eds. Health and human rights: a reader. London, Routledge:54–71.
                     Hall W (1997) The role of legal coercion in the treatment of offenders with alcohol
                     and heroin problems. Australian and New Zealand Journal of Criminology,
                     30:103–120.
                     Hall W, Sannibale C (1996) Are there two types of alcoholism? Lancet, 348:1258.


                                                     237




          Chapter_7                237                             19.1.2004, 11:51
   253   254   255   256   257   258   259   260   261   262   263